West Virginia HB 5553: Relating to participation in federal prescription drug pricing programs.

Status: To House Health and Human Resources (as of 2026-02-16)

State: West Virginia · Session: 2026 · Bill: HB 5553

Subjects: Health

Sponsors: Holstein, Cannon, J., Funkhouser, Linville, Rohrbach

View West Virginia HB 5553 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.